How to cut healthcare costs in Massachusetts: ban Harvard from insurance plans
Massachusetts Governor Patrick discusses how they are cutting healthcare costs by encouraging limited network plans that do not include Harvard and other teaching hospitals, as well as getting away...
View ArticleThe Medicare CMMI pork project needs to be nipped in the bud
For PDF version, click here CMMI needs to be dismantled May 27, 2012 By Steven Greer, MD The Supreme Court will soon announce its ruling on the constitutionality of the PPACA “Obamacare” law that was...
View ArticleActual tweets of Boston terrorist bomber Dzhokhar A. Tsarnaev
April 19, 2013- Below are the actual Tweets of the surviving Boston terrorist bomber, Dzhokhar A. Tsarnaev. He is a fan of HipHop culture, likely has no girlfriend but wants one, seems to be enrolled...
View ArticleFDA official, William Maisel, pleads guilty to crime, keeps job
April 24, 2013 By Steven E. Greer, MD In July of 2012, the New York Times reported on an FDA scandal of the agency spying on internal whistleblowers, by hacking into their work and personal emails. The...
View ArticleJennifer Temel, MD, Vicki Jackson, MD: Early palliative care improves...
Produced and interviewed by Steven Greer, MD A group from Harvard published a paper in The NEJM that showed early initiation of palliative care in a group of lung cancer patients resulted in improved...
View ArticleBenjamin Sommers, MD PhD: the challenges of expanding Medicaid
Interviewed by Steven Greer, MD Under the ACA health insurance reform laws, approximately 16 million new Medicaid patients will be added to the system within a few years. Benjamin Sommers, MD PhD,...
View ArticleDon Berwick, MD: National Coverage Decisions
National Coverage Decisions (NCDs) are used by CMS to set guidelines as to when certain therapies will be covered and reimbursed based on the best scientific clinical data. NCD’s tend to result in...
View ArticlePaul Richardson, MD: Three-drug regimen for multiple myeloma
Dr. Paul Richardson of Harvard’s Dana-Farber Cancer Institute reviews the recent Lancet article by Cavo, et al, that was the first randomized controlled trial to compare three-drug regimen (bortezomib...
View ArticlePaul Richardson, MD: Current Therapies for Multiple Myeloma
Interviewed by Steven Greer, MD Dr. Paul Richardson, Clinical Director of the Multiple Myeloma Center at Harvard’s Dana-Farber Cancer Institute gives an overview of the current standard of care for...
View Article
